Understanding where it sits relative to other options helps you evaluate whether your current protocol is optimized and whether alternative or complementary approaches might enhance your results
The classes of diabetes drugs looked at in the study included insulins, metformin, DPP-4 inhibitors, SGLT-2 inhibitors, sulfonylureas, thiazolidinediones and other GLP-1's than Ozempic.
If they feel the need to keep their trade secret, run dont walk out of their office
Tirzepatide is a once-weekly injectable dual glucagon-like peptide 1 (GLP-1) receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
Control Release 116 (1), 127
Patients self-inject this medication under the skin of the abdomen or thigh, similar to how one might administer an insulin pen